Public Hearing Regarding Section 301 Investigation of Germany’s Persistent Underpayment for Innovative Pharmaceutical Products
WASHINGTON — The Office of the United States Trade Representative (USTR) will hold a public hearing on September 22, 2026, regarding the Section 301 investigation into Germany’s acts, policies, and practices related to the persistent underpayment for innovative pharmaceutical products.
The hearing will take place in the main hearing room of the U.S. International Trade Commission, at 500 E Street SW, Washington, DC, starting at 10:00 am ET.
Please consult the USTR website for the hearing schedule.
Note: The hearing is on the record but no external cameras or video recording will be allowed in the hearing room. The hearing will not be livestreamed. A full transcript of the hearing will be posted on ustr.gov after the hearing. Please contact media@ustr.eop.gov with questions or for more information on media arrangements.
###
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
